Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease

NCT00028093 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Peginterferon alfa-2a with Ribavirin
DRUG: Peginterferon alfa-2a

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)